Nitric oxide (NO) is used in numerous commercial and industrial applications. As a raw material it is used in the semiconductor industry for surface oxidation processes. As a synthesis gas, NO is used in the preparation of nitric acid, hydroxylamine, nitrosyl chloride, metal nitrosyls, and caprolactam, which is used in the synthesis of nylon. Nitric oxide is also used commercially as a polymerization inhibitor during the preparation of olefins and to modify the properties of various polymers.
Several processes have been developed for the preparation of nitric oxide. Commercially, NO is produced by the Ostwald process in which ammonia is oxidized at temperatures near 800° C. in the presence of a platinum group catalyst. Nitric oxide can also be produced from the reaction of nitric acid and copper or the reaction of sodium nitrate and sulfuric acid. These methods are not convenient for small scale NO production due to the power requirements for heating the reaction mixtures to several hundred degrees Celsius and the hazards inherent in handling strong acids. Several processes have been proposed for bench-scale production of nitric oxide for on-site use in laboratories, production facilities and medical facilities. Attention is directed to U.S. Pat. Nos. 3,853,790; 3,948,610; 4,272,336; 4,774,069; 4,812,300; 5,396,882; 5,478,549; 5,670,127; 5,683,668; 5,692,495; 5,827,420; 6,103,275; 6,534,029; 6,743,404; 6,758,214; 7,025,869; 7,040,313 and 7,048,951. Each of these methods has disadvantages relative to the photolysis of nitrous oxide (N2O). For example, some require toxic starting materials or produce toxic byproducts such as nitrogen dioxide (NO2), while others require high temperatures, high voltages or use of strong acids.
In the analysis of air and other gases for nitric oxide, it is necessary to calibrate the analytical instrument using a gas standard having a known concentration of NO. The most common method used for NO detection is based on chemiluminescence in the reaction of NO with an excess of ozone. The method, which is widely used for air pollution monitoring, for measurements of NO in automobile exhaust and for measurements of NO in exhaled breath, requires frequent calibration with a standard gas mixture. Nitric oxide measurements based on electrochemical techniques, chemiluminescence with luminol and other methods require calibration using a gas standard as well.
A well known problem with NO gas standards is that NO is unstable in gas cylinders at low concentrations; when NO standards are prepared at part-per-billion by volume (ppbv) levels there is a strong tendency for the concentration of NO in the cylinder to decline with time even though the NO is diluted into an unreactive gas such as nitrogen. One reason for this is that NO is thermodynamically unstable with respect to disproportionation to form N2O and NO2 according to the equilibrium:
3NO=N2O+NO2 (3)
Although extremely slow in the gas phase, this reaction may be catalyzed on the interior walls of compressed gas cylinders. The walls may be treated in various ways to slow the reaction, but the treatment is not always effective, and one cannot be certain that the concentration of NO in a gas cylinder is what it was when the cylinder was first filled. Furthermore, even trace amounts of oxygen (O2) in the diluent gas can react to oxidize NO to NO2 according to the well known reaction:
2NO+O2→2NO2 (4)
Also, because of reaction 4, NO compressed gas standards cannot be made with air as the diluent. This is a disadvantage since it is desirable to calibrate an NO instrument using the same diluent gas as the gas being analyzed, which is most commonly air.
Nitric oxide standards are much more stable at high concentrations of NO; thus, it is common to prepare gas standards at the high ppmv level in an unreactive gas such as N2 to make a compressed gas standard and then dynamically dilute that standard with N2 or air prior to entering the analytical instrument being calibrated. Although the dynamic dilution method works well for calibration, flow meters are required, and the flow meters must be accurately calibrated, thus adding to the complexity, expense and uncertainty of the calibration procedure.
Nitric oxide has several medical applications. Blood vessels use nitric oxide to signal the surrounding smooth muscle to relax, thus dilating the artery and increasing blood flow. This underlies the action of nitroglycerin, amyl nitrate and other nitrate derivatives in the treatment of heart disease; the compounds undergo reactions that release nitric oxide, which in turn dilates the blood vessels around the heart, thereby increasing its blood supply.
Some disorders or physiological conditions can be mediated by inhalation of nitric oxide. Dilation of pulmonary vessels in the lungs due to inhaled NO causes pulmonary gas exchange to be improved and pulmonary blood flow to be increased. The administration of low concentrations of inhaled nitric oxide can prevent, reverse, or limit the progression of disorders such as acute pulmonary vasoconstriction, adult respiratory distress syndrome, acute pulmonary edema, acute mountain sickness, post cardiac surgery acute pulmonary hypertension, persistent pulmonary hypertension in a newborn, perinatal aspiration syndrome, and asthma. For inhalation therapy, it is important that the NO gas mixture be free of the toxic gas NO2 which can form inside compressed gas cylinders.
The present invention provides a simple method for the production of nitric oxide from a non-hazardous, gas-phase precursor. Without the need for high temperatures, strong acids, and aqueous solution, the invention allows NO to be produced from a small apparatus for portable, on-site use. The concentration of NO produced can be accurately controlled, thereby making the NO source highly useful as a calibration device for analytical instruments that measure nitric oxide in gases.
The foregoing example of the related art and limitations related therewith are intended to be illustrative and not exclusive. Other limitations of the related art will become apparent to those of skill in the art upon a reading of the specification and a study of the drawings.
One aspect of this invention is a means to produce NO by exposing N2O to ultraviolet light.
Another aspect of the invention is to dilute NO produced by exposure of N2O to UV light into air, oxygen or a gas mixture for the purpose of inhalation therapy. For example, the NO/gas mixture could be administered to newborn babies, especially those born prematurely.
Another aspect of the invention is to dilute NO produced by exposure of N2O to UV light with air, nitrogen or another gas for calibration of analytical instruments that measure NO such as nitric oxide monitors used to measure NO in ambient air, automotive exhaust and analyzers that measure NO in exhaled breath.
Another aspect of this invention is to control the concentration or mixing ratio of NO produced by controlling the UV light intensity, pressure, temperature, N2O flow rate and/or diluent gas flow rate, with particular attention given to control of the UV light intensity.
Another aspect of this invention is to produce concentrations of gases other than NO at controlled levels by using different reagent gas sources.
Disclosed herein is a method for producing nitric oxide by exposing nitrous oxide (N2O) to ultraviolet light in a controlled environment. This method has advantages over other methods of producing NO. For example, only one chemical reagent (N2O) is required, and this reagent is relatively non toxic (used at mixing ratios of up to 50% in air as an anesthetic) and commercially available in small cartridges as a consumer product for making whipped cream. The only significant byproducts produced are nitrogen and oxygen, the major components of air. For applications where it is desirable or necessary to remove the unreacted N2O, methods for the catalytic decomposition of N2O into N2 and O2 have been developed. In this regard, reference is made to U.S. Pat. Nos. 5,314,673; 6,347,627; 6,429,168 and 6,743,404. The simplicity of the method described here provides for a compact, low power, portable NO source in which the concentration of NO produced is easily controlled.
The same apparatus designed for producing calibrated concentrations of NO in a diluent gas by photolysis of N2O may, with either no or only minor modifications, be used to produce calibrated concentrations of other gases as well. For example, if N2O is replaced with carbon dioxide (CO2), the same apparatus may be used to produce controlled concentrations of carbon monoxide (CO). If N2O is replaced with SF6, calibrated concentrations of molecular fluorine (F2) in a diluent gas can be produced. In fact, concentrations of many different gases may be produced by proper choice of the reagent gas.
These and other features and advantages of the disclosed method with the chosen components and the combination thereof, the mode and operation and use, as well become apparent from the following description, reference being made to the accompanying drawings that form a part of this specification wherein like reference characters designate corresponding parts in several views. The embodiments and features thereof are described and illustrated in conjunction with systems, tools and methods which are meant to exemplify and to illustrate, not being limiting in scope.
The following embodiments and aspects thereof are described and illustrated in conjunction with systems, tool and methods which are meant to be exemplary and illustrative, not limiting in scope. In various embodiments, one or more of the above described problems have been reduced or eliminated, while other embodiments are directed to other improvements.
Before explaining the disclosed embodiment of the present invention in detail, it is to be understood that the invention is not limited in its application to the details of the particular arrangement shown, since the invention is capable of other embodiments. Exemplary embodiments are illustrated in referenced figures of the drawings. It is intended that the embodiments and figures disclosed herein are to be considered illustrative rather than limiting. Also, the terminology used herein is for the purpose of description and not of limitation.
In this method N2O is photolyzed in the absence of ambient air to produce electronically excited oxygen atoms, which then react with N2O to produce NO as follows:
N2O+hv→N2+O(1D2) (1)
O(1D2)+N2O→N2+O2 (2)
Net: 2N2O→2N2+O2 (3)
and
N2O+hv→N2+O(1D2) (4)
O(1D2)+N2O→2NO (5)
Net: 2N2O→2NO+N2 (6)
Here, O(1D2) is an electronically excited state of the oxygen atom. N2O has a broad absorption band in the wavelength region 160-260 nm, and the quantum yield for reaction 1 is unity at wavelengths shorter than the thermodynamic limit of 230 nm (NASA, 2006). It is believed that the most efficient wavelengths for the conversion are between 170 to 190 nm, inclusive. In pure N2O, O(1D2) reacts with N2O to form two sets of products, either N2+O2 (reaction 3) or 2NO (reaction 5). The two sets of products are produced with yields of 41% and 59%, at 298 K, respectively based on the measured rate coefficients for reactions 3 and 5 (NASA, 2006).
Another possible fate of the O(1D2) atom produced in reaction 1 is deactivation to the ground state according to the following reaction:
O(1D2)+M→O+M (7)
Here, M is any molecule or atom, principally N2O. In reaction 7, a ground state oxygen atom is formed. It has been reported that less than 4% of O(1D2) produced in the presence of N2O is collisionally deactivated to ground state atoms (Wine and Ravishankara, 1982). To the extent that it is formed, the primary fate of this O atom is recombination to form molecular oxygen:
O+O+M→O2+M (8)
Again, M is any molecule or atom, principally N2O.
The only byproducts produced in reactions 1-8 are N2 and O2, the principal components of air. Significantly, the reaction system does not directly produce the toxic gas nitrogen dioxide (NO2). Potentially, nitrogen dioxide could be produced in the secondary reaction
2NO+O2→NO2 (9)
where the O2 is derived from reaction 2 and to a much smaller extent from reaction 8. However, reaction 9 has a small rate coefficient and is second order in NO concentration, with the result that reaction conditions can be chosen where the concentration of NO2 produced is insignificant. As an example, in inhalation therapy the concentration of NO administered is typically in the range 20-100 part per million (ppmv). In order to produce 100 ppmv NO in air with a 1% dilution of the N2O/NO source gas into air, the concentration of NO in the N2O source gas would need to be 10,000 ppmv. The corresponding amount of oxygen produced in reaction 2 would be 3,500 ppmv. Using the rate coefficient of 1.9 e−38 cm6 molec−2 S−2 at 298 K for reaction 9 (NBS, 1977), the half life for reaction of 10,000 ppmv NO in the presence of 3,500 ppmv O2 is calculated to be 0.7 hours, and for a 10 second residence time in the photolysis chamber the NO2 concentration produced is 40 ppmv, which after diluted into air is 0.4 ppmv. By comparison, the U.S. Occupational Safety and Health Administration permissible exposure limit (PEL) to NO2 is 5 ppmv and 8 hour time weighted average (TWA) is 3 ppmv.
Referring first to
Referring next to
Unreacted N2O, NO and other reaction products flow out of reaction chamber 13, into connecting tube 16, and are mixed with a flow of NO-scrubbed air in tube 25. The NO/air mixture, having a substantially constant NO concentration, exits tube 25 and may be sampled by a NO measurement device for the purpose of calibration. The NO-scrubbed air is produced by drawing in ambient air by air pump 18 through inlet 17. The air then passes through connecting tube 19, through NO scrubber 20, through connecting tube 21, through flow controller 22, through connecting tube 23, through flow meter 24 and into tube 25. For a fixed lamp intensity, the mixing ratio of NO exiting tube 25 may be varied by varying the diluent air flow rate using flow controller 22. Because the absorption of UV light is nearly optically thick (nearly every photon of sufficient energy to cause photolysis is absorbed by N2O), the output mixing ratio of NO is nearly insensitive to the flow rate of N2O.
The apparatus of
2×(CO2+hv→CO+O) (10)
O+O+M→O2+M (11)
Net: 2CO2+2hv→2CO+O2
Thus, the photolysis reaction can be used to produce a controlled concentration of CO and O2. Again, the CO2 flowing into the reaction chamber 1 purges the reaction chamber of substantially all of the ambient air. Although a low pressure mercury lamp can be used to produce low concentrations of CO according to this mechanism, a preferred lamp would be a hydrogen or deuterium lamp, because the lamp emission spectrum better overlaps that of the CO2 absorption spectrum.
Similarly, if the N2O source is replaced with a source of sulfur hexafluoride (SF6), then a controlled concentration of SF4 and F2 could be produced according to the sequence of reactions:
SF6+hv→SF5+F (12)
SF5+F→SF4+F2 (13)
Net: 2SF6→2SF4+F2
Many other reagents can be photolyzed with ultraviolet light. In many of these, the presence of ambient air will cause the photolysis to produce a gas product or products such as ozone. However, if the photolysis in done in the absence of ambient air, a different, and possibly more desirable gas product will be formed. As would be known by the practitioner of the art, a number of gases could be used to produce either the gas products discussed above, or other reaction products, the key being that the concentration of the gas product is controlled by a combination of lamp intensity, flow rate of gas through the photolysis chamber and flow rate of diluent gas. The apparatus of
Referring next to
In a second example, the apparatus of
While a number of exemplary aspects and embodiments have been discussed above, those of skill in the art will recognize certain modifications, permutations, additions and sub-combinations therefore. It is therefore intended that the following appended claims hereinafter introduced are interpreted to include all such modifications, permutations, additions and sub-combinations are within their true spirit and scope. Each apparatus embodiment described herein has numerous equivalents.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US08/61535 | 4/25/2008 | WO | 00 | 10/14/2009 |
Number | Date | Country | |
---|---|---|---|
60914087 | Apr 2007 | US |